49 research outputs found
Near-Infrared Light Activated Azo-BF<sub>2</sub> Switches
Increasing the electron density in
BF<sub>2</sub>-coodinated azo
compounds through <i>para</i>-substitution leads to a bathochromic
shift in their activation wavelength. When the substituent is dimethyl
amine, or the like, the <i>trans</i>/<i>cis</i> isomerization process can be efficiently modulated using near infrared
light. The electron donating capability of the substituent also controls
the hydrolysis half-life of the switch in aqueous solution, which
is drastically longer for the <i>cis</i> isomer, while the
BF<sub>2</sub>-coodination prevents reduction by glutathione
Visible Light Switching of a BF<sub>2</sub>‑Coordinated Azo Compound
Here we report the synthesis and characterization of
a BF<sub>2</sub>–azo complex that can be induced to isomerize
without the
need of deleterious UV light. The complexation of the azo group with
BF<sub>2</sub>, coupled with the extended conjugation of the Nî—»N
π-electrons, increases the energy of the n−π* transitions
and introduces new π-nonbonding (π<sub>nb</sub>) to π*
transitions that dominate the visible region. The well separated π<sub>nb</sub>–π* transitions of the <i>trans</i> and <i>cis</i> isomers enable the efficient switching
of the system by using only visible light. The complexation also leads
to a slow <i>cis</i> → <i>trans</i> thermal
relaxation rate (<i>t</i><sub>1/2</sub> = 12.5 h). Theoretical
calculations indicate that the absorption bands in the visible range
can be tuned using different Lewis acids, opening the way to a conceptually
new strategy for the manipulation of azo compounds using only visible
light
Near-Infrared Light Activated Azo-BF<sub>2</sub> Switches
Increasing the electron density in
BF<sub>2</sub>-coodinated azo
compounds through <i>para</i>-substitution leads to a bathochromic
shift in their activation wavelength. When the substituent is dimethyl
amine, or the like, the <i>trans</i>/<i>cis</i> isomerization process can be efficiently modulated using near infrared
light. The electron donating capability of the substituent also controls
the hydrolysis half-life of the switch in aqueous solution, which
is drastically longer for the <i>cis</i> isomer, while the
BF<sub>2</sub>-coodination prevents reduction by glutathione
Visible Light Switching of a BF<sub>2</sub>‑Coordinated Azo Compound
Here we report the synthesis and characterization of
a BF<sub>2</sub>–azo complex that can be induced to isomerize
without the
need of deleterious UV light. The complexation of the azo group with
BF<sub>2</sub>, coupled with the extended conjugation of the Nî—»N
π-electrons, increases the energy of the n−π* transitions
and introduces new π-nonbonding (π<sub>nb</sub>) to π*
transitions that dominate the visible region. The well separated π<sub>nb</sub>–π* transitions of the <i>trans</i> and <i>cis</i> isomers enable the efficient switching
of the system by using only visible light. The complexation also leads
to a slow <i>cis</i> → <i>trans</i> thermal
relaxation rate (<i>t</i><sub>1/2</sub> = 12.5 h). Theoretical
calculations indicate that the absorption bands in the visible range
can be tuned using different Lewis acids, opening the way to a conceptually
new strategy for the manipulation of azo compounds using only visible
light
Galvanic Replacement-Free Deposition of Au on Ag for Core–Shell Nanocubes with Enhanced Chemical Stability and SERS Activity
We
report a robust synthesis of Ag@Au core–shell nanocubes
by directly depositing Au atoms on the surfaces of Ag nanocubes as
conformal, ultrathin shells. Our success relies on the introduction
of a strong reducing agent to compete with and thereby block the galvanic
replacement between Ag and HAuCl<sub>4</sub>. An ultrathin Au shell
of 0.6 nm thick was able to protect the Ag in the core in an oxidative
environment. Significantly, the core–shell nanocubes exhibited
surface plasmonic properties essentially identical to those of the
original Ag nanocubes, while the SERS activity showed a 5.4-fold further
enhancement owing to an improvement in chemical enhancement. The combination
of excellent SERS activity and chemical stability may enable a variety
of new applications
Transformation of Ag Nanocubes into Ag–Au Hollow Nanostructures with Enriched Ag Contents to Improve SERS Activity and Chemical Stability
We report a strategy to complement
the galvanic replacement reaction between Ag nanocubes and HAuCl<sub>4</sub> with co-reduction by ascorbic acid (AA) for the formation
of Ag–Au hollow nanostructures with greatly enhanced SERS activity.
Specifically, in the early stage of synthesis, the Ag nanocubes are
sharpened at corners and edges because of the selective deposition
of Au and Ag atoms at these sites. In the following steps, the pure
Ag in the nanocubes is constantly converted into Ag<sup>+</sup> ions
to generate voids owing to the galvanic reaction with HAuCl<sub>4</sub>, but these released Ag<sup>+</sup> ions are immediately reduced
back to Ag atoms and are co-deposited with Au atoms onto the nanocube
templates. We observe distinctive SERS properties for the Ag–Au
hollow nanostructures at visible and near-infrared excitation wavelengths.
When plasmon damping is eliminated by using an excitation wavelength
of 785 nm, the SERS activity of the Ag–Au hollow nanostructures
is 15- and 33-fold stronger than those of the original Ag nanocubes
and the Ag–Au nanocages prepared by galvanic replacement without
co-reduction, respectively. Additionally, Ag–Au hollow nanostructures
embrace considerably improved stability in an oxidizing environment
such as aqueous H<sub>2</sub>O<sub>2</sub> solution. Collectively,
our work suggests that the Ag–Au hollow nanostructures will
find applications in SERS detection and imaging
Schematic representation of the lineage relationships of the cell types examined in these studies
<p><b>Copyright information:</b></p><p>Taken from "CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents and "</p><p>http://jbiol.com/content/5/7/22</p><p>Journal of Biology 2006;5(7):22-22.</p><p>Published online 30 Nov 2006</p><p>PMCID:PMC2000477.</p><p></p> Pluripotent neuroepithelial stem cells (NSC) give rise to glial-restricted precursor (GRP) cells and neuron-restricted precursor (NRP) cells. NRP cells can give rise to multiple populations of neurons, whereas GRP cells give rise to astrocytes and oligodendrocyte-type-2 astrocytes (O-2A/OPCs). The O-2A/OPCs in turn give rise to oligodendrocytes. The progenitor cells that lie between NSCs and differentiated cell types, and are the major dividing cell population in the CNS, appear to be exceptionally vulnerable to the effects of chemotherapeutic agents. Also sharing this vulnerability are nondividing oligodendrocytes
Representative images of co-labeling for TUNEL and expression of cell type-specific antigens
<p><b>Copyright information:</b></p><p>Taken from "CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents and "</p><p>http://jbiol.com/content/5/7/22</p><p>Journal of Biology 2006;5(7):22-22.</p><p>Published online 30 Nov 2006</p><p>PMCID:PMC2000477.</p><p></p> Despite the apparent labeling of nuclei with cell-type specific antibodies in dying cells (presumably due to the changes in antigen distribution associated with nuclear fragmentation), co-labeling was highly cell-type specific (see also Figure 7 for -stack analysis). NG2/TUNELcells from the CC. In this and subsequent rows, the first image is of TUNEL staining, the next two images are of staining for the proteins indicated, and the merged image is on the far right. DCX/TUNELcells from SVZ; GFAP/TUNELcell from DG. NeuN/TUNELcell from DG. In all merged images except (l) co-labeled cells show up as yellow; in (l) the nucleus of the co-labeled cell is green. Magnification 400×
Primary CNS cells are equally or more vulnerable to cytarabine than cancer cells
<p><b>Copyright information:</b></p><p>Taken from "CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents and "</p><p>http://jbiol.com/content/5/7/22</p><p>Journal of Biology 2006;5(7):22-22.</p><p>Published online 30 Nov 2006</p><p>PMCID:PMC2000477.</p><p></p> Cells were plated on coverslips in 24-well plates at a density of 1,000 cells per well and allowed to grow for 24–48 h. On the basis of drug concentrations achieved in human patients, cells were exposed to cytarabine for 24 h. Cell survival and viability was determined after additional 24–48 h (see Materials and methods). Rat neural cell types studied included O-2A/OPCs, oligodendrocytes, GRP cells, NSCs and astrocytes. We also examined the T98 glioma cell line, a meningioma cell line, and the L1210 and EL-4 leukemia cell lines. To define the onset of cytarabine toxicity, cells were treated with cytarabine over a wide dose range (0.01–1 μM) extending downwards from the lower ranges achieved in high-dose therapy. Each experiment was carried out in quadruplicate and was repeated multiple times in independent experiments. Data represent mean of survival ± SEM, normalized to control values. There are no concentrations of cytarabine at which tumor cell lines were more sensitive O-2A/OPCs or oligodendrocytes